CD8A and neoplasm: Glycolytic CAFs can also influence immune cell function, for example, by upregulating CXCL16, a T cell‐retention chemokine that restricts CD8+ T cells to the tumor periphery, and suppressing DOX‐induced immunogenic cell death [129, 152].